ADEL BOUTROS: Open Payments
NPI 1700952827 · LAKE FOREST, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$366 in 15 payments from 7 companies in 2025. Trend: 2023 $714 · 2024 $439 · 2025 $366
Food & beverage: $366
| Company | Payments | Amount |
|---|---|---|
| Vanda Pharmaceuticals Inc. | 5 | $136 |
| Teva Pharmaceuticals USA, Inc. | 3 | $69 |
| Amgen Inc. | 2 | $38 |
| Corcept Therapeutics | 1 | $37 |
| AstraZeneca Pharmaceuticals LP | 2 | $32 |
| Neurocrine BioSciences, Inc. | 1 | $27 |
| Lilly USA, LLC | 1 | $26 |
Products named: HETLIOZ, AUSTEDO XR, Korlym, AIRSUPRA, INGREZZA, KISUNLA, UZEDY, REPATHA.
Industry payments across CA — which companies pay providers there.
